Treatment options for breast cancer that has spread to the liver
Part of Cancer, Skin clinical trials.
This study looks at how breast cancer that has spread to the liver responds to different treatments, including surgery and medicines. The goal is to learn which approach works best for patients with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- You have breast cancer that has spread to the liver (BCLM).
- You may also have cancer in other parts of the body beyond the liver.
- You have received or are willing to receive any kind of treatment for your cancer.
- You are able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a local (targeted) approach for breast cancer that has spread to the liver. It looks at whether treating liver metastases with planned liver surgery, along with standard cancer treatment before and after, can improve outcomes.
This study collects health information from patients with cancer that has spread to the liver. Researchers will track your medical history and outcomes to better understand how metastatic liver cancer develops and progresses.
This trial compares two surgical approaches for removing liver metastases from colon cancer: anatomical resection versus nonanatomical resection. It aims to see which approach works better for people whose tumors have certain genetic changes or are on the right side of the colon.
This study observes people with stomach cancer that has spread to the liver. It looks at how the disease progresses and how patients respond to their usual treatments over time.
This trial studies people who have liver metastases from cancers other than colorectal cancer and are undergoing surgery to remove them. It aims to gather data on outcomes after liver resection.
This Phase 1 study tests whether targeted radiation to liver tumors combined with immunotherapy can control metastatic non-small cell lung cancer. It aims to find a safe and effective treatment approach for people whose cancer has spread to the liver.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.